How will the results of the study potentially open additional revenue streams or government contracts for Momentus?

Fundamental outlook

The NASA‑awarded study is a “proof‑of‑concept” that positions Momentus (MNTS) as a go‑to provider of in‑space logistics and robotic payload delivery. If the study validates the performance of its foundational robotics and in‑orbit transportation system, Momentus can immediately submit a follow‑on mission proposal—a step that historically translates into multi‑year, multi‑million‑dollar NASA contracts (often 5‑ to 10‑year extensions). Beyond NASA, a successful demonstration unlocks a pipeline of ancillary revenue: commercial satellite operators, defense agencies, and emerging lunar‑surface ventures will need the same low‑cost, high‑reusability transport capability. In practice, each new flight could generate a $10‑$15 million payload‑delivery fee plus ancillary services (e.g., on‑orbit servicing, refueling, and robotic integration), diversifying Momentus’ income away from its current satellite‑deployment focus.

Market and technical implications

The study’s completion already moved the stock higher on the news, creating a short‑term technical bias that can be leveraged. Assuming the study’s results are released in the next 4‑6 weeks, the event will act as a catalyst; a positive data set typically triggers a “buy‑the‑dip” rally, especially if the follow‑on proposal is filed before the next earnings window (Q3 2025). Traders should watch for:

• Volume spikes on the study release – a surge confirms market appetite.
• Break of the $1.00 resistance level (historical 52‑week high) – a clean close above signals the start of a higher‑high, lower‑low pattern, inviting a breakout long.
• Relative Strength Index (RSI) staying below 70 – indicates room for upside without overbought exhaustion.

Actionable take‑away

If the study confirms the technology and Momentus announces a follow‑on mission proposal, consider entering a long position with a tight stop just below the recent low (~$0.92) and targeting the next resistance at $1.20–$1.30, where prior pull‑backs have stalled. Conversely, if the study is inconclusive or delayed, the stock could face a corrective pull‑back toward the $0.85‑$0.88 support zone, offering a short‑bias entry. In either scenario, the outcome of the study is a near‑term catalyst that can materially expand Momentus’ revenue base and government contract pipeline, making the stock highly sensitive to the forthcoming data release.